Clinical Trial Update: Safety, Efficacy, and Pharmacodynamics of a 60-Minute Infusion of Carfilzomib for Progressive Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluating the safety, early efficacy, and pharmacodynamics of a 60-minute infusion of carfilzomib for progressive multiple myeloma in P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)

Snippet

Sponsor: Oncotherapeutics | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN